Back to Journals » OncoTargets and Therapy » Volume 7

Review

Clinical response to sunitinib as a multitargeted tyrosine-kinase inhibitor (TKI) in solid cancers: a review of clinical trials

       
Total article views   HTML views PDF downloads Totals
13,130 Dovepress* 10,643+ 2,281 12,924
PubMed Central* 2,487 881 3,368
Totals 13,130 3,162 16,292
*Since 12 May 2014
+Since July 2016

View citations on PubMed Central and Google Scholar